A pilot trial of S-1 plus irinotecan chemotherapy for esophageal adenocarcinoma.
Nakajima Y, Fujiwara N, Ryotokuji T, Ohta S, Okada T, Miyawaki Y, Hoshino A, Jirawat S, Tokairin Y, Kawada K, Nishikage T, Nagai K, Kawano T.
Nakajima Y, et al. Among authors: nagai k.
Hepatogastroenterology. 2012 Oct;59(119):2182-5. doi: 10.5754/hge11997.
Hepatogastroenterology. 2012.
PMID: 22366525